We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effect of Positive Airway Pressure on Heart Rate Variability

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00289666
Recruitment Status : Completed
First Posted : February 10, 2006
Last Update Posted : July 11, 2016
Sponsor:
Information provided by (Responsible Party):
Raelene Maser, Christiana Care Health Services

Brief Summary:
This study is designed to determine the effect of continuous positive airway pressure (CPAP) or bi-level positive airway pressure (BiPAP) on heart rate variability (HRV) in patients with obstructive sleep apnea (OSA).

Condition or disease
Obstructive Sleep Apnea

  Show Detailed Description

Study Type : Observational
Estimated Enrollment : 38 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: A Prospective Study to Determine the Effect of Positive Airway Pressure on Heart Rate Variability in Individuals With Obstructive Sleep Apnea
Study Start Date : July 2003
Primary Completion Date : March 2007
Study Completion Date : September 2008

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Sleep Apnea
U.S. FDA Resources




Biospecimen Retention:   Samples Without DNA
Serum, Plasma, Urine


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 75 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Tertiary Care
Criteria

Inclusion Criteria:

  • Individuals aged 18-75 years old.
  • Individuals with diagnosed OSA.

Exclusion Criteria:

  • 1. Individuals who are receiving treatment for OSA, excluding those being treated by weight loss.

    2. Individuals who have had pharyngeal surgery (i.e., uvulopalatopharyngoplasty).

    3. Individuals who have arterial oxygen desaturation episodes or apneic episodes not felt to be due to OSA.

    4. Individuals whose treatment dosage changes 2 months prior to, or during, the study for antihypertensive and antidiabetic medications and the following medications that may affect the autonomic nervous system: anti-tuberculosis drugs, nitrofurantoin, metronidazole, chloramphenicol, perhexiline maleate, cordarone, clofibrate, tricyclic antidepressants, phenytoin, barbiturates, neuroleptic drugs, antiparkinsonism drugs, and nitrated drugs.


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00289666


Locations
United States, Delaware
Christiana Care Health Service
Newark, Delaware, United States, 19713
Sponsors and Collaborators
Christiana Care Health Services
Investigators
Principal Investigator: Raelene E Maser, PhD University of Delaware

Publications:
Responsible Party: Raelene Maser, Associate Professor, Christiana Care Health Services
ClinicalTrials.gov Identifier: NCT00289666     History of Changes
Other Study ID Numbers: 23011
First Posted: February 10, 2006    Key Record Dates
Last Update Posted: July 11, 2016
Last Verified: September 2008

Keywords provided by Raelene Maser, Christiana Care Health Services:
Sleep Disorder
CPAP

Additional relevant MeSH terms:
Sleep Apnea Syndromes
Sleep Apnea, Obstructive
Apnea
Respiration Disorders
Respiratory Tract Diseases
Sleep Disorders, Intrinsic
Dyssomnias
Sleep Wake Disorders
Nervous System Diseases